BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 28440099)

  • 1. Antibiotic susceptibility of Helicobacter pylori in Iceland.
    Gunnarsdottir AI; Gudjonsson H; Hardardottir H; Jonsdottir KD; Bjornsson ES
    Infect Dis (Lond); 2017 Sep; 49(9):647-654. PubMed ID: 28440099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.
    Dekhnich N; Ivanchik N; Kozlov R; Alimov A; Steshits A; Kirsov P; Pandav K
    Helicobacter; 2018 Dec; 23(6):e12545. PubMed ID: 30324756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori: Multiple resistance in patients from Bogotá, Colombia.
    Arévalo A; Otero WA; Trespalacios AA
    Biomedica; 2019 May; 39(s1):125-134. PubMed ID: 31529855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes.
    Yang YJ; Wu CT; Ou HY; Lin CH; Cheng HC; Chang WL; Chen WY; Yang HB; Lu CC; Sheu BS
    Ann Med; 2017 Sep; 49(6):479-486. PubMed ID: 28266875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility testing before first-line treatment for
    Cosme A; Montes M; Ibarra B; Tamayo E; Alonso H; Mendarte U; Lizasoan J; Herreros-Villanueva M; Bujanda L
    World J Gastroenterol; 2017 May; 23(18):3367-3373. PubMed ID: 28566898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.
    Wu IT; Chuah SK; Lee CH; Liang CM; Lu LS; Kuo YH; Yen YH; Hu ML; Chou YP; Yang SC; Kuo CM; Kuo CH; Chien CC; Chiang YS; Chiou SS; Hu TH; Tai WC
    World J Gastroenterol; 2015 Oct; 21(37):10669-74. PubMed ID: 26457027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
    Di Giulio M; Di Campli E; Di Bartolomeo S; Cataldi V; Marzio L; Grossi L; Ciccaglione AF; Nostro A; Cellini L
    Scand J Gastroenterol; 2016 Mar; 51(3):263-9. PubMed ID: 26554617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for
    Miftahussurur M; Cruz M; Subsomwong P; Jiménez Abreu JA; Hosking C; Nagashima H; Akada J; Yamaoka Y
    Am J Trop Med Hyg; 2017 May; 96(5):1050-1059. PubMed ID: 28193745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANTIBIOTIC RESISTANCE SURVEILLANCE OF HELICOBACTER PYLORI AT THE BIOBÍO REGION (CHILE) IN A DECADE.
    Parra-Sepúlveda C; Merino JS; Sáez-Carrillo K; González C; García-Cancino A
    Arq Gastroenterol; 2019; 56(4):361-366. PubMed ID: 31721972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016.
    Fiorini G; Zullo A; Saracino IM; Pavoni M; Vaira D
    Scand J Gastroenterol; 2018 Jun; 53(6):661-664. PubMed ID: 29688095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey.
    Caliskan R; Tokman HB; Erzin Y; Saribas S; Yuksel P; Bolek BK; Sevuk EO; Demirci M; Yılmazli O; Akgul O; Kalayci F; Cakan H; Salih B; Bal K; Kocazeybek B
    Rev Soc Bras Med Trop; 2015; 48(3):278-84. PubMed ID: 26108005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned?
    Boltin D; Ben-Zvi H; Perets TT; Kamenetsky Z; Samra Z; Dickman R; Niv Y
    J Clin Microbiol; 2015 Feb; 53(2):522-7. PubMed ID: 25428158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
    Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
    Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of antibiotic resistance amongst isolates of
    Garvey E; Rhead J; Suffian S; Whiley D; Mahmood F; Bakshi N; Letley D; White J; Atherton J; Winter JA; Robinson K
    J Med Microbiol; 2023 Nov; 72(11):. PubMed ID: 37962209
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan.
    Chang WL; Sheu BS; Cheng HC; Yang YJ; Yang HB; Wu JJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1230-5. PubMed ID: 19476562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia.
    Hu S; Zhou Y; Deng Y; Bo Y; Chen X; Yang W; Shi R; Zhao W; Hou Z; Hu J; Liu J; Zhang X; Yong H; Wang P; Li F; Qi H; Wang X; Jin L; Cui T; Yong H; Li X; Yang B; Yu Y; Ma B; Fu L; Wang X; Ma Z; Tang N; You Y; Guo J; Yu X; Yao L; Gao R; Li Y; Xin R; Liu J; Cao Z; Li H; Ma L; Ma S; Cao Y; Tang Y; Liu J; Hao Q; Li X; Li X; Mu R; Niu M; Su X; Gao H
    Helicobacter; 2023 Jun; 28(3):e12960. PubMed ID: 37042045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
    Aktaş B; Başyiğit S; Yüksel O; Akkan T; Atbaşı ST; Uzman M; Yılmaz B; Şimşek G; Nazlıgül Y
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):769-75. PubMed ID: 25919773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
    John A; Al Kaabi S; Doiphode S; Chandra P; Sharma M; Babu R; Yacoub R; Derbala M
    Indian J Gastroenterol; 2015 Sep; 34(5):404-7. PubMed ID: 26541342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
    Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y
    BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.